Clinical ink Appoints Andrew Kraus as Chief Technology Officer
Clinical Ink announced the appointment of Andrew Kraus as Chief Technology Officer. Andrew Kraus is an accomplished global healthcare executive with a 30-year track record of successful innovation in clinical trials. In this role, he will lead the development of Clinical Ink’s expanding technology portfolio to support clinical trials. He previously served as Chief Operating Officer for World Care Clinical and held executive roles at Bioclinica, Signant, and the Cardiovascular Research Foundation.
Clinical Ink is a technology company that specializes in providing eSource solutions for clinical trials, enabling electronic data capture and streamlining the data collection process.